Problem
Concentrated tech, pharma, agribusiness, and retail power raises prices, crushes startups, and buys political influence. Decades of weak merger enforcement treated monopoly as efficient until consumers and workers paid the bill.
Proposed Fix
Restore aggressive Clayton and Sherman Act enforcement. Ban mergers above bright-line market-share thresholds unless proven to benefit consumers and workers. Structural separation for dominant platforms' adjacent lines of business. Fund FTC and DOJ Antitrust hiring. Private right of action expansions for workers harmed by no-poach and wage collusion.
Economic Impact
Lower consumer prices and higher startup formation. Worker wage gains where labor-market concentration falls. Reduced political spending power from fewer mega-firms.
Cost of Inaction
Without revival, mergers keep raising prices and shrinking choice across tech, pharma, and retail. FTC and DOJ capacity gaps leave monopoly conduct cheaper than compliance.
Safeguards
- Worker and consumer harm tests in merger review, not price alone
- Cooling-off bans on revolving-door moves from FTC/DOJ to client firms
- Public merger-challenge memos for rejected and accepted deals
- Circuit-split review commission to restore coherent antitrust doctrine
Evidence & framing
Competition lowers prices and widens opportunity. Breakups and bright-line merger rules prevent monopolies from becoming faits accomplis that regulators can only fine after the damage.
Related Legislation
- Congress.gov - Antitrust legislation
Track merger bright-line and platform separation bills
Implementation Timeline
- CapacityYear 1
Double FTC/DOJ antitrust staffing; issue bright-line merger guidelines.
- Structural casesYear 2-4
Pursue breakups and separations in dominant platform and pharma markets.
- Labor collusionYear 2-5
No-poach and wage-fixing enforcement with private rights of action.
Sources: